$ZTS
Zoetis Inc.

2013 Q2 Form 10-Q Financial Statement

#000155528013000042 Filed on August 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q2
Revenue $1.114B
YoY Change 6.4%
Cost Of Revenue $416.0M
YoY Change 5.85%
Gross Profit $698.0M
YoY Change 6.73%
Gross Profit Margin 62.66%
Selling, General & Admin $399.0M
YoY Change 18.05%
% of Gross Profit 57.16%
Research & Development $95.00M
YoY Change -6.86%
% of Gross Profit 13.61%
Depreciation & Amortization $51.00M
YoY Change 6.25%
% of Gross Profit 7.31%
Operating Expenses $494.0M
YoY Change 12.27%
Operating Profit $204.0M
YoY Change -4.67%
Interest Expense $32.00M
YoY Change 300.0%
% of Operating Profit 15.69%
Other Income/Expense, Net $10.00M
YoY Change
Pretax Income $187.0M
YoY Change 9.36%
Income Tax $59.00M
% Of Pretax Income 31.55%
Net Earnings $128.0M
YoY Change 15.32%
Net Earnings / Revenue 11.49%
Basic Earnings Per Share $0.26
Diluted Earnings Per Share $0.26
COMMON SHARES
Basic Shares Outstanding 500.0M shares
Diluted Shares Outstanding 500.2M shares

Balance Sheet

Concept 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $369.0M
YoY Change 226.55%
Cash & Equivalents $369.0M
Short-Term Investments
Other Short-Term Assets $227.0M
YoY Change -32.24%
Inventory $1.257B
Prepaid Expenses
Receivables $1.137B
Other Receivables $0.00
Total Short-Term Assets $3.082B
YoY Change 22.01%
LONG-TERM ASSETS
Property, Plant & Equipment $1.252B
YoY Change 0.81%
Goodwill $982.0M
YoY Change
Intangibles $834.0M
YoY Change
Long-Term Investments
YoY Change
Other Assets $57.00M
YoY Change -75.54%
Total Long-Term Assets $3.179B
YoY Change -5.95%
TOTAL ASSETS
Total Short-Term Assets $3.082B
Total Long-Term Assets $3.179B
Total Assets $6.261B
YoY Change 6.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $587.0M
YoY Change 193.5%
Accrued Expenses $157.0M
YoY Change 12.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $12.00M
YoY Change
Total Short-Term Liabilities $1.321B
YoY Change 64.1%
LONG-TERM LIABILITIES
Long-Term Debt $3.640B
YoY Change 528.67%
Other Long-Term Liabilities $131.0M
YoY Change -47.6%
Total Long-Term Liabilities $3.771B
YoY Change 354.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.321B
Total Long-Term Liabilities $3.771B
Total Liabilities $5.438B
YoY Change 175.76%
SHAREHOLDERS EQUITY
Retained Earnings $109.0M
YoY Change
Common Stock $5.000M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $800.0M
YoY Change
Total Liabilities & Shareholders Equity $6.261B
YoY Change 6.01%

Cashflow Statement

Concept 2013 Q2
OPERATING ACTIVITIES
Net Income $128.0M
YoY Change 15.32%
Depreciation, Depletion And Amortization $51.00M
YoY Change 6.25%
Cash From Operating Activities -$12.00M
YoY Change 200.0%
INVESTING ACTIVITIES
Capital Expenditures -$58.00M
YoY Change -287.1%
Acquisitions
YoY Change
Other Investing Activities $6.000M
YoY Change 200.0%
Cash From Investing Activities -$52.00M
YoY Change 57.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -32.00M
YoY Change -145.07%
NET CHANGE
Cash From Operating Activities -12.00M
Cash From Investing Activities -52.00M
Cash From Financing Activities -32.00M
Net Change In Cash -96.00M
YoY Change -382.35%
FREE CASH FLOW
Cash From Operating Activities -$12.00M
Capital Expenditures -$58.00M
Free Cash Flow $46.00M
YoY Change -231.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1011000000 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
974000000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-183000000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1137000000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
900000000 USD
CY2012Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
159000000 USD
CY2013Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
38000000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
319000000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
587000000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-157000000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
869000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12000000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20000000 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6000000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34000000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
49000000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16000000 USD
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
31000000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3000000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
6000000 USD
CY2012Q4 us-gaap Assets
Assets
6262000000 USD
CY2013Q2 us-gaap Assets
Assets
6261000000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
3082000000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2864000000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
317000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
369000000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106000000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
52000000 USD
CY2013Q2 us-gaap Commercial Paper
CommercialPaper
0 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.065
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.13
CY2012Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000.000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
500000000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
500000000 shares
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
5000000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
156000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
248000000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
94000000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11000000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
248000000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
94000000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
11000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
157000000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
416000000 USD
CY2012Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
378000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
771000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
818000000 USD
CY2012Q4 us-gaap Debt Current
DebtCurrent
73000000 USD
CY2013Q2 us-gaap Debt Current
DebtCurrent
12000000 USD
CY2013Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3650000000 USD
CY2013Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
10000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-26000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-19000000 USD
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
92000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
101000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
216000000 USD
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
54000000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
8000000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
165000000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
3000000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
2000000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
323000000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
308000000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
308000000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
323000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
102000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
102000000 USD
CY2012Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54000000 USD
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
51000000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
62000000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
65000000 USD
CY2012Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2013Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
33000000 USD
CY2013Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
33000000 USD
CY2012Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 USD
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.293
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.326
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.316
CY2012Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.313
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
194000000 USD
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
157000000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
441000000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
412000000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
379000000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1154000000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1154000000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
713000000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
742000000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000000 USD
CY2012Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-12000000 USD
CY2013Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2000000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2013Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000000 USD
CY2012Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-14000000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
985000000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
982000000 USD
CY2012Q4 us-gaap Goodwill Gross
GoodwillGross
1521000000 USD
CY2013Q2 us-gaap Goodwill Gross
GoodwillGross
1518000000 USD
CY2013Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
536000000 USD
CY2012Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
536000000 USD
CY2013Q2 us-gaap Goodwill Other Changes
GoodwillOtherChanges
-3000000 USD
CY2012Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
3000000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
3000000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1000000 USD
CY2013Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
423000000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
187000000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
252000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
138000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
111000000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59000000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000000 USD
CY2013Q2 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
2000000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
147000000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26000000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
306000000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
115000000 USD
CY2013Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
121000000 USD
CY2012Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
126000000 USD
CY2012Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1280000000 USD
CY2013Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1275000000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
834000000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
868000000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
32000000 USD
us-gaap Interest Expense
InterestExpense
54000000 USD
us-gaap Interest Expense
InterestExpense
16000000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
8000000 USD
us-gaap Interest Paid Net
InterestPaidNet
23000000 USD
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
844000000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
799000000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
1257000000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
1345000000 USD
CY2012Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
214000000 USD
CY2013Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
186000000 USD
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
227000000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
332000000 USD
us-gaap Legal Fees
LegalFees
2000000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
2221000000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
5438000000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6261000000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6262000000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1123000000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1321000000 USD
CY2013Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
0 USD
CY2013Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2013Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
400000000 USD
CY2013Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2013Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3640000000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2013Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
14000000 USD
CY2012Q3 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
-19000000 USD
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 USD
CY2013Q2 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 USD
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
-19000000 USD
CY2013Q2 us-gaap Loss Contingency Receivable Current
LossContingencyReceivableCurrent
14000000 USD
CY2013Q2 us-gaap Minority Interest
MinorityInterest
23000000 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
15000000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Zoetis Inc. (collectively, Zoetis, the company, we, us or our) is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. We organize and operate our business in </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">four</font><font style="font-family:inherit;font-size:9pt;"> geographic regions: the United States (U.S.); Europe/Africa/Middle East (EuAfME); Canada/Latin America (CLAR); and Asia/Pacific (APAC). </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We market our products in more than </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">120</font><font style="font-family:inherit;font-size:9pt;"> countries, including developed markets and emerging markets. Our revenues are mostly generated in the U.S. and EuAfME. We have a diversified business, marketing products across </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">eight</font><font style="font-family:inherit;font-size:9pt;"> core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:9pt;"> major product categories (anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals).</font></div></div>
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-140000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-59000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
70000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
269000000 USD
us-gaap Net Income Loss
NetIncomeLoss
284000000 USD
us-gaap Net Income Loss
NetIncomeLoss
268000000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
173000000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
128000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2012Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2013Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
120
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 segment
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
227000000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
201000000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
57000000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
88000000 USD
CY2012Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-3000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
0 USD
CY2013Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-1000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-128000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33000000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-162000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-20000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-128000000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-162000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-34000000 USD
us-gaap Other Increase Decrease In Environmental Liabilities
OtherIncreaseDecreaseInEnvironmentalLiabilities
-7000000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
131000000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
107000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1000000 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2012Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
20000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
26000000 USD
CY2013Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
10000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
5000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3000000 USD
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
62000000 USD
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
33000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
80000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55000000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2624000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-184000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
80000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
12000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Profit Loss
ProfitLoss
268000000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
128000000 USD
us-gaap Profit Loss
ProfitLoss
285000000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
173000000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1241000000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1252000000 USD
CY2012Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
92000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
185000000 USD
CY2013Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
95000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
194000000 USD
us-gaap Restructuring Charges
RestructuringCharges
-27000000 USD
CY2013Q2 us-gaap Restructuring Reserve
RestructuringReserve
18000000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
74000000 USD
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
-14000000 USD
CY2013Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
9000000 USD
CY2012Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
63000000 USD
CY2013Q2 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
9000000 USD
CY2012Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
11000000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
109000000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
13000000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
13000000 USD
CY2012Q3 us-gaap Royalty Revenue
RoyaltyRevenue
7000000 USD
CY2013Q2 us-gaap Royalty Revenue
RoyaltyRevenue
5000000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1114000000 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1094000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2141000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2204000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
756000000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
399000000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
344000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
682000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
31000000 USD
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.010
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.282
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0129
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
25894 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2948882 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.02
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14000000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2922988 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.00
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.05
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
0 shares
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
26.00
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
26.05
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y7M0D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P0Y
CY2013Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
12000000 USD
CY2012Q4 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.037
CY2013Q2 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.046
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
4026000000 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
800000000 USD
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
823000000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4041000000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3736000000 USD
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3931000000 USD
CY2012Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
30000000 USD
CY2013Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
83000000 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
35000000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
144000000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
164000 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
217000 shares
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
500000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
500164000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
500000000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
500217000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
500000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
500000000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
500000000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
500000000 shares
zts Adjustments To Additional Paid In Capital Consideration Paid To Related Party
AdjustmentsToAdditionalPaidInCapitalConsiderationPaidToRelatedParty
-3551000000 USD
zts Allocated Share Based Compensation Expense Allocated From Parent Company
AllocatedShareBasedCompensationExpenseAllocatedFromParentCompany
0 USD
CY2013Q2 zts Allocated Share Based Compensation Expense Allocated From Parent Company
AllocatedShareBasedCompensationExpenseAllocatedFromParentCompany
0 USD
zts Allocated Share Based Compensation Expense Allocated From Parent Company
AllocatedShareBasedCompensationExpenseAllocatedFromParentCompany
5000000 USD
CY2012Q3 zts Allocated Share Based Compensation Expense Allocated From Parent Company
AllocatedShareBasedCompensationExpenseAllocatedFromParentCompany
3000000 USD
zts Allocated Share Based Compensation Expense Direct And Indirect Expense
AllocatedShareBasedCompensationExpenseDirectAndIndirectExpense
31000000 USD
CY2013Q2 zts Allocated Share Based Compensation Expense Direct And Indirect Expense
AllocatedShareBasedCompensationExpenseDirectAndIndirectExpense
20000000 USD
CY2012Q3 zts Allocated Share Based Compensation Expense Direct And Indirect Expense
AllocatedShareBasedCompensationExpenseDirectAndIndirectExpense
9000000 USD
zts Allocated Share Based Compensation Expense Direct And Indirect Expense
AllocatedShareBasedCompensationExpenseDirectAndIndirectExpense
17000000 USD
zts Amortization Of Intangible Assets Not Associated With Single Function
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
32000000 USD
CY2012Q3 zts Amortization Of Intangible Assets Not Associated With Single Function
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
16000000 USD
CY2013Q2 zts Amortization Of Intangible Assets Not Associated With Single Function
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
15000000 USD
zts Amortization Of Intangible Assets Not Associated With Single Function
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
30000000 USD
zts Business Separation Adjustments
BusinessSeparationAdjustments
450000000 USD
zts Contributed Capital Associatedwith Pension Paidby Pfizer
ContributedCapitalAssociatedwithPensionPaidbyPfizer
0 USD
zts Cost Reduction Initiatives And Acquisition Costs
CostReductionInitiativesAndAcquisitionCosts
-9000000 USD
zts Cost Reduction Initiatives And Acquisition Costs
CostReductionInitiativesAndAcquisitionCosts
65000000 USD
CY2012Q3 zts Cost Reduction Initiatives And Acquisition Costs
CostReductionInitiativesAndAcquisitionCosts
27000000 USD
CY2013Q2 zts Cost Reduction Initiatives And Acquisition Costs
CostReductionInitiativesAndAcquisitionCosts
-19000000 USD
CY2012Q4 zts Current Deferred Tax Liabilities And Other Current Liabilities
CurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities
507000000 USD
CY2013Q2 zts Current Deferred Tax Liabilities And Other Current Liabilities
CurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities
449000000 USD
zts Debt Issued To Related Party For Net Asset Transfers
DebtIssuedToRelatedPartyForNetAssetTransfers
0 USD
zts Debt Issued To Related Party For Net Asset Transfers
DebtIssuedToRelatedPartyForNetAssetTransfers
992000000 USD
CY2012Q4 zts Line Of Credit Facility Covenant Compliance Minimum Interest Coverage Ratio
LineOfCreditFacilityCovenantComplianceMinimumInterestCoverageRatio
3.50
CY2013Q2 zts Long Term Debt Maturities Repayments Of Principal After Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearSix
2500000000 USD
CY2013Q2 zts Long Term Debt Maturities Repayments Of Principal In Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix
750000000 USD
CY2012Q4 zts Long Term Debt Parent Company
LongTermDebtParentCompany
509000000 USD
CY2013Q2 zts Long Term Debt Parent Company
LongTermDebtParentCompany
0 USD
CY2013Q2 zts Number Of Core Animal Species Marketed
NumberOfCoreAnimalSpeciesMarketed
8 species
CY2013Q2 zts Number Of Major Product Categories
NumberOfMajorProductCategories
5 product_categories
CY2013Q2 zts Numberof Regional Segments
NumberofRegionalSegments
4 region
zts Other Comprehensive Income Loss Net Of Tax Separation Adjustments
OtherComprehensiveIncomeLossNetOfTaxSeparationAdjustments
-6000000 USD
CY2013Q2 zts Parent Company Investment
ParentCompanyInvestment
0 USD
CY2012Q4 zts Parent Company Investment
ParentCompanyInvestment
4183000000 USD
zts Payment To Related Party In Connection With Asset Transfer
PaymentToRelatedPartyInConnectionWithAssetTransfer
0 USD
zts Payment To Related Party In Connection With Asset Transfer
PaymentToRelatedPartyInConnectionWithAssetTransfer
2559000000 USD
CY2013Q1 zts Property Plant And Equipment Number Of Manufacturing Facilities
PropertyPlantAndEquipmentNumberOfManufacturingFacilities
29 manufacturing_site
zts Reclassification Of Net Liability Due To Related Party
ReclassificationOfNetLiabilityDueToRelatedParty
60000000 USD
CY2013Q2 zts Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
-20000000 USD
CY2012Q3 zts Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
24000000 USD
zts Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
-13000000 USD
zts Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
49000000 USD
zts Restructuring Reserve Utilization And Other
RestructuringReserveUtilizationAndOther
15000000 USD
zts Revenue Denominated In Foreign Currency
RevenueDenominatedInForeignCurrency
322000000 USD
CY2012Q3 zts Revenue Denominated In Foreign Currency
RevenueDenominatedInForeignCurrency
158000000 USD
zts Revenue Denominated In Foreign Currency
RevenueDenominatedInForeignCurrency
334000000 USD
CY2013Q2 zts Revenue Denominated In Foreign Currency
RevenueDenominatedInForeignCurrency
166000000 USD
CY2013Q1 zts Share Based Compensation Arrangement By Share Based Payment Award Number Of Employees
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfEmployees
1700
zts Stock Issued During Period Value New Issues And Reclassification Of Unit Equity
StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfUnitEquity
0 USD
zts Stockholders Equity Net Transfers Between Related Party And Noncontrolling Interests
StockholdersEquityNetTransfersBetweenRelatedPartyAndNoncontrollingInterests
0 USD
zts Stockholders Equity Net Transfers To Related Party
StockholdersEquityNetTransfersToRelatedParty
88000000 USD
zts Stockholders Equity Net Transfers To Related Party
StockholdersEquityNetTransfersToRelatedParty
-271000000 USD
CY2012Q4 zts Unrecognized Tax Benefits Interest Related To Unrecognized Tax Benefits
UnrecognizedTaxBenefitsInterestRelatedToUnrecognizedTaxBenefits
17000000 USD
CY2013Q2 zts Unrecognized Tax Benefits Interest Related To Unrecognized Tax Benefits
UnrecognizedTaxBenefitsInterestRelatedToUnrecognizedTaxBenefits
9000000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001555280
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
500000000 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Zoetis Inc.
dei Trading Symbol
TradingSymbol
ZTS

Files In Submission

Name View Source Status
0001555280-13-000042-index-headers.html Edgar Link pending
0001555280-13-000042-index.html Edgar Link pending
0001555280-13-000042.txt Edgar Link pending
0001555280-13-000042-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R53.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R54.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R55.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R56.xml Edgar Link unprocessable
R57.htm Edgar Link pending
R57.xml Edgar Link unprocessable
R58.htm Edgar Link pending
R58.xml Edgar Link unprocessable
R59.htm Edgar Link pending
R59.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R60.htm Edgar Link pending
R60.xml Edgar Link unprocessable
R61.htm Edgar Link pending
R61.xml Edgar Link unprocessable
R62.htm Edgar Link pending
R62.xml Edgar Link unprocessable
R63.htm Edgar Link pending
R63.xml Edgar Link unprocessable
R64.htm Edgar Link pending
R64.xml Edgar Link unprocessable
R65.htm Edgar Link pending
R65.xml Edgar Link unprocessable
R66.htm Edgar Link pending
R66.xml Edgar Link unprocessable
R67.htm Edgar Link pending
R67.xml Edgar Link unprocessable
R68.htm Edgar Link pending
R68.xml Edgar Link unprocessable
R69.htm Edgar Link pending
R69.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R70.htm Edgar Link pending
R70.xml Edgar Link unprocessable
R71.htm Edgar Link pending
R71.xml Edgar Link unprocessable
R72.htm Edgar Link pending
R72.xml Edgar Link unprocessable
R73.htm Edgar Link pending
R73.xml Edgar Link unprocessable
R74.htm Edgar Link pending
R74.xml Edgar Link unprocessable
R75.htm Edgar Link pending
R75.xml Edgar Link unprocessable
R76.htm Edgar Link pending
R76.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
zoetis-2013630x10q.htm Edgar Link pending
zoetis-2013630xex101.htm Edgar Link pending
zoetis-2013630xex12.htm Edgar Link pending
zoetis-2013630xex15.htm Edgar Link pending
zoetis-2013630xex311.htm Edgar Link pending
zoetis-2013630xex312.htm Edgar Link pending
zoetis-2013630xex321.htm Edgar Link pending
zoetis-2013630xex322.htm Edgar Link pending
zts-20130630.xml Edgar Link completed
zts-20130630.xsd Edgar Link pending
zts-20130630_cal.xml Edgar Link unprocessable
zts-20130630_def.xml Edgar Link unprocessable
zts-20130630_lab.xml Edgar Link unprocessable
zts-20130630_pre.xml Edgar Link unprocessable